back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-05-11 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,883 vol |
||
| Filed 2016-05-11 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$218,729
+1,883 vol $116.16 each |
1,883 | |
| Filed 2016-05-10 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-10 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,883 vol |
1,883 | |
| Filed 2015-11-04 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,934,468 | ||
| Filed 2015-11-04 Tx date 2015-10-25 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Morfit, Garrison Mason
4 - Director of Issuer
Holder: ValueAct Co-Invest Master Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,059,793 |